UMass Cancer Center News

Dohoon Kim, PhD, and colleagues have shown that blocking a specific detoxifying enzyme in lung cancer cells leads to cell death, making it a viable target for drug development.

Vaccination against COVID-19 was linked to reduced inflammation in response to SARS-CoV-2 infection, according to a paper co-authored by UMass Chan Medical School researcher Jonathan M. Gerber, MD.

The Research Scholar Grant will support Dr. Ruscetti’s research on senescent cells and their role in tumor progression and immune suppression in prostate cancer.

UMass Chan Medical School scientists Phillip D. Zamore, PhD, and Roger J. Davis, PhD, FRS, were elected to the National Academy of Medicine on Oct. 9 for their distinguished contributions to medicine and health.

More than a dozen of Michael Green’s former colleagues, trainees and others are scheduled to speak at the symposium.

These highly accomplished faculty members have been appointed to endowed chairs at UMass Chan Medical School: Dale L. Greiner, PhD; Danny G. Winder, PhD; Elinor K. Karlsson, PhD; Jeannette M. Wolfe, MD; J. Kevin Donahue, MD; and John E. Harris, MD, PhD’05.

More than 2,000 people took part in the 25th annual UMass Cancer Walk presented by Harr Toyota at Polar Park on Sunday, Sept. 24. Participants raised more than $700,000 to support adult and pediatric cancer research and clinical trials at UMass Chan Medical School.

The 2023 UMass Cancer Walk presented by Harr Toyota marks the 25th year of commitment to cancer research. Many participants and sponsors have a personal connection to cancer and have supported the event for years.

Four faculty members were honored with chancellor’s medals and four others were invested as endowed professors at the Convocation and Investiture ceremony at UMass Chan Medical School.

Nicholas Harper, a PhD candidate in the Interdisciplinary Graduate Program, has received a prestigious award from the National Cancer Institute to study cell death as it relates to cancer therapies.